Montesinos MR. Discurso del Presidente entrante de la Academia Argenꢁna de Cirugía. Rev Argent Cir. 2025;117(2):e-dacadmrm
3
sermon is to have a good beginning and a good ending; methods of those treaꢀng penile or paroꢀd cancer, it
and to have the two as close together as possible.” would not have been possible to discover, refine, and
And I will begin by asking you to answer the apply a technique that led to a significant reducꢀon in
following quesꢀons for yourselves: What do I expect the morbidity of surgical treatment for thousands of
from the Academia Argenꢀna de Cirugía? And how can paꢀents. The same could be said of the expansion of
I contribute to the Academia Argenꢀna de Cirugía?
laparoscopy from cholecystectomy to appendectomy,
My speech will focus on how I answered these colectomy, cephalic pancreaꢀcoduodenectomy (CPD),
quesꢀons for myself. Keeping that in mind, I would like hepatectomy, and even thoracoscopic and cervical ap-
to begin with a story that started in 1960 when Ernest proaches (TOETVA).
Gould et alia published a paper in the Cancer journal
In short, we learn from others, from those who
about a “senꢀnel lymph node” in paroꢀd cancer. They do things differently ..., not by monotonously repeaꢀng
observed a few cases in which when paroꢀd cancer the same thing with the same people, as this approach
metastasized to a lymph node, which they called “sen- does not lead to progress or innovaꢀon and causes us
ꢀ
nel lymph node” because of its constant anatomical to fall into the dangerous trap of confirmaꢀon bias.
locaꢀon (between the anterior and posterior facial ve- I recall Miguel de Unamuno (1864-1036): “The
ins, what we would now consider level IIA), metastases spiritual greed of those who, knowing something, do
were present in the remaining lymph nodes, and when not seek the transmission of that knowledge, is detes-
metastases were absent in the senꢀnel lymph node, table”.
they were also absent in the remaining lymph nodes.
In another aspect, it is possible to affirm the
Because of its originality at that ꢀme, the term was pla- diversity of the human populaꢀon: different races, eth-
ced in quotaꢀon marks.
niciꢀes, ages, sexes, sociocultural and economic status,
A disease like cancer does not manifest itself
Despite the detailed nature of the study, it had and access to medical care.
no impact on the specialty. A few years later, in 1977,
Dr. Ramón Cabañas, a Paraguayan surgeon trained at with similar incidence in different geographical regions.
Memorial Sloan-Keꢁering in New York, published a pa- The prevalence of different types of cancer va-
per in the same journal on penile cancer, a prevalent di- ries by country.
sease in his country. He also noted the correspondence
Within a single country like the United States,
between the pathological status of a lymph node with a as many as ten different “Americas” have recently been
precise anatomical locaꢀon and the remaining inguinal described, each with a different life expectancy at birth.
lymph nodes. And he also called it senꢀnel lymph node.
I wonder: Will the same thing happen in a cou-
A few years later, Donald Morton, a California- ntry like Argenꢀna, with such a large area and diverse
based surgeon who specialized in the treatment of me- populaꢀon?
lanoma, concluded that examining a lymph node could
Ulꢀmately, given so many differences in the
help resolve the controversy surrounding the treatment populaꢀon, are health issues manifested and mana-
of stage I melanoma—that is, melanoma without clini- ged in the same manner everywhere? This has led to
cally evident regional lymph node metastasis. Unlike a growing interest in publicaꢀons and is referred to as
previous studies, the lymph node had to be examined dispariꢀes, making it essenꢀal to validate the results of
in each individual case, due to the ubiquity of the con- different treatments in local populaꢀons.
diꢀon, using a procedure called “lymphaꢀc mapping.”
Let us also bear in mind the words of William
Aꢃer facing some resistance, his study was published in Osler (1849–1919): “The credit goes to the man who
the Archives of Surgery in 1992. Since then, it has be- convinces the world, not to the man to whom the idea
come a seminal work in developing and disseminaꢀng first occurs.”
the technique.
However, the volume of scienꢀfic publicaꢀons
In 1993, David Krag adopted the procedure for also varies across different regions, with a greater pre-
breast cancer using a radiopharmaceuꢀcal, and Arman- dominance in the Northern Hemisphere and in English-
do Giuliano published his observaꢀons in 1994, also on speaking countries.
breast cancer, using dye.
In conclusion, and to answer the quesꢀons po-
While this technique is currently being leꢃ sed earlier,
aside in some cases, it is not due to any demonstrated
What do I expect from the Academia? I expect
safety, inaccuracy, or reproducibility issues. Rather, it it to offer me the opportunity to learn up-to-date in-
is a result of the significant advancements in systemic formaꢀon on unfamiliar topics that I can apply to my
treatments.
This procedure was developed and validated
by pracꢀcing surgeons, not laboratory scienꢀsts.
pracꢀce or specialty.
How can I contribute to the Academia? By
communicaꢀng what I do, its strengths and limitaꢀons,
What lesson have I learned from this? If those which reflect the reality in my community, in order to
treaꢀng breast cancer had not expanded their scope to receive feedback and try to improve, because it is va-
consider the approaches of their colleagues in melano- luable to know what is happening in our environment.
ma, or if those treaꢀng melanoma had not explored the
I am not opꢀmisꢀc, but I have hope. As Byung-